The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Influenza Subunit Vaccine Market Research Report 2025
Synopsis
Influenza subunit vaccine is a type of vaccine used to prevent influenza. It contains specific protein subunits of the influenza virus, usually the influenza virus hemagglutinin and neuraminidase. These subunits stimulate the body's immune system to produce antibodies that provide protection when infected with the influenza virus.
The global Influenza Subunit Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Influenza Subunit Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Influenza Subunit Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Influenza Subunit Vaccine include Ab&B BIO-TECH, Sanofi, Seqirus, Inc, Zhongyianke Biology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Influenza Subunit Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Subunit Vaccine.
The Influenza Subunit Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Influenza Subunit Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Subunit Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ab&B BIO-TECH
Sanofi
Seqirus, Inc
Zhongyianke Biology
Segment by Type
Trivalent Vaccines
Tetravalent Vaccine
Segment by Application
Aldult
Child
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Influenza Subunit Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Influenza Subunit Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Influenza subunit vaccine is a type of vaccine used to prevent influenza. It contains specific protein subunits of the influenza virus, usually the influenza virus hemagglutinin and neuraminidase. These subunits stimulate the body's immune system to produce antibodies that provide protection when infected with the influenza virus.
The global Influenza Subunit Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Influenza Subunit Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Influenza Subunit Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Influenza Subunit Vaccine include Ab&B BIO-TECH, Sanofi, Seqirus, Inc, Zhongyianke Biology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Influenza Subunit Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Subunit Vaccine.
The Influenza Subunit Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Influenza Subunit Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Subunit Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ab&B BIO-TECH
Sanofi
Seqirus, Inc
Zhongyianke Biology
Segment by Type
Trivalent Vaccines
Tetravalent Vaccine
Segment by Application
Aldult
Child
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Influenza Subunit Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Influenza Subunit Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Influenza Subunit Vaccine Market Overview
1.1 Product Definition
1.2 Influenza Subunit Vaccine by Type
1.2.1 Global Influenza Subunit Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Trivalent Vaccines
1.2.3 Tetravalent Vaccine
1.3 Influenza Subunit Vaccine by Application
1.3.1 Global Influenza Subunit Vaccine Market Value by Application (2024-2030)
1.3.2 Aldult
1.3.3 Child
1.4 Global Influenza Subunit Vaccine Market Size Estimates and Forecasts
1.4.1 Global Influenza Subunit Vaccine Revenue 2019-2030
1.4.2 Global Influenza Subunit Vaccine Sales 2019-2030
1.4.3 Global Influenza Subunit Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Influenza Subunit Vaccine Market Competition by Manufacturers
2.1 Global Influenza Subunit Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Influenza Subunit Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Influenza Subunit Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Influenza Subunit Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Influenza Subunit Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza Subunit Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Influenza Subunit Vaccine, Date of Enter into This Industry
2.8 Global Influenza Subunit Vaccine Market Competitive Situation and Trends
2.8.1 Global Influenza Subunit Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Influenza Subunit Vaccine Players Market Share by Revenue
2.8.3 Global Influenza Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Influenza Subunit Vaccine Market Scenario by Region
3.1 Global Influenza Subunit Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Influenza Subunit Vaccine Sales by Region: 2019-2030
3.2.1 Global Influenza Subunit Vaccine Sales by Region: 2019-2024
3.2.2 Global Influenza Subunit Vaccine Sales by Region: 2025-2030
3.3 Global Influenza Subunit Vaccine Revenue by Region: 2019-2030
3.3.1 Global Influenza Subunit Vaccine Revenue by Region: 2019-2024
3.3.2 Global Influenza Subunit Vaccine Revenue by Region: 2025-2030
3.4 North America Influenza Subunit Vaccine Market Facts & Figures by Country
3.4.1 North America Influenza Subunit Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Influenza Subunit Vaccine Sales by Country (2019-2030)
3.4.3 North America Influenza Subunit Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Influenza Subunit Vaccine Market Facts & Figures by Country
3.5.1 Europe Influenza Subunit Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Influenza Subunit Vaccine Sales by Country (2019-2030)
3.5.3 Europe Influenza Subunit Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza Subunit Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Influenza Subunit Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Influenza Subunit Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Influenza Subunit Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Influenza Subunit Vaccine Market Facts & Figures by Country
3.7.1 Latin America Influenza Subunit Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Influenza Subunit Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Influenza Subunit Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Influenza Subunit Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza Subunit Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Influenza Subunit Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Influenza Subunit Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Influenza Subunit Vaccine Sales by Type (2019-2030)
4.1.1 Global Influenza Subunit Vaccine Sales by Type (2019-2024)
4.1.2 Global Influenza Subunit Vaccine Sales by Type (2025-2030)
4.1.3 Global Influenza Subunit Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Influenza Subunit Vaccine Revenue by Type (2019-2030)
4.2.1 Global Influenza Subunit Vaccine Revenue by Type (2019-2024)
4.2.2 Global Influenza Subunit Vaccine Revenue by Type (2025-2030)
4.2.3 Global Influenza Subunit Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Influenza Subunit Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Influenza Subunit Vaccine Sales by Application (2019-2030)
5.1.1 Global Influenza Subunit Vaccine Sales by Application (2019-2024)
5.1.2 Global Influenza Subunit Vaccine Sales by Application (2025-2030)
5.1.3 Global Influenza Subunit Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Influenza Subunit Vaccine Revenue by Application (2019-2030)
5.2.1 Global Influenza Subunit Vaccine Revenue by Application (2019-2024)
5.2.2 Global Influenza Subunit Vaccine Revenue by Application (2025-2030)
5.2.3 Global Influenza Subunit Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Influenza Subunit Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ab&B BIO-TECH
6.1.1 Ab&B BIO-TECH Company Information
6.1.2 Ab&B BIO-TECH Description and Business Overview
6.1.3 Ab&B BIO-TECH Influenza Subunit Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ab&B BIO-TECH Influenza Subunit Vaccine Product Portfolio
6.1.5 Ab&B BIO-TECH Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Influenza Subunit Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Influenza Subunit Vaccine Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Seqirus, Inc
6.3.1 Seqirus, Inc Company Information
6.3.2 Seqirus, Inc Description and Business Overview
6.3.3 Seqirus, Inc Influenza Subunit Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Seqirus, Inc Influenza Subunit Vaccine Product Portfolio
6.3.5 Seqirus, Inc Recent Developments/Updates
6.4 Zhongyianke Biology
6.4.1 Zhongyianke Biology Company Information
6.4.2 Zhongyianke Biology Description and Business Overview
6.4.3 Zhongyianke Biology Influenza Subunit Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zhongyianke Biology Influenza Subunit Vaccine Product Portfolio
6.4.5 Zhongyianke Biology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza Subunit Vaccine Industry Chain Analysis
7.2 Influenza Subunit Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza Subunit Vaccine Production Mode & Process
7.4 Influenza Subunit Vaccine Sales and Marketing
7.4.1 Influenza Subunit Vaccine Sales Channels
7.4.2 Influenza Subunit Vaccine Distributors
7.5 Influenza Subunit Vaccine Customers
8 Influenza Subunit Vaccine Market Dynamics
8.1 Influenza Subunit Vaccine Industry Trends
8.2 Influenza Subunit Vaccine Market Drivers
8.3 Influenza Subunit Vaccine Market Challenges
8.4 Influenza Subunit Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Influenza Subunit Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Influenza Subunit Vaccine Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Influenza Subunit Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Influenza Subunit Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Influenza Subunit Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Influenza Subunit Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Influenza Subunit Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Influenza Subunit Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Influenza Subunit Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Influenza Subunit Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Influenza Subunit Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Influenza Subunit Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Influenza Subunit Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Subunit Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Influenza Subunit Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Influenza Subunit Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Influenza Subunit Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Influenza Subunit Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Influenza Subunit Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Influenza Subunit Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Influenza Subunit Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Influenza Subunit Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Influenza Subunit Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Influenza Subunit Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Influenza Subunit Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Influenza Subunit Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Influenza Subunit Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Influenza Subunit Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Influenza Subunit Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Influenza Subunit Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Influenza Subunit Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Influenza Subunit Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Influenza Subunit Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Influenza Subunit Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Influenza Subunit Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Influenza Subunit Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Influenza Subunit Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Influenza Subunit Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Influenza Subunit Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Influenza Subunit Vaccine Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Influenza Subunit Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Influenza Subunit Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Influenza Subunit Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Influenza Subunit Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Influenza Subunit Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Influenza Subunit Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Influenza Subunit Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Influenza Subunit Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Influenza Subunit Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Influenza Subunit Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Influenza Subunit Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Influenza Subunit Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Influenza Subunit Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Influenza Subunit Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Influenza Subunit Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Influenza Subunit Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Influenza Subunit Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Influenza Subunit Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Influenza Subunit Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Influenza Subunit Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Influenza Subunit Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Influenza Subunit Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Influenza Subunit Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Influenza Subunit Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Influenza Subunit Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Ab&B BIO-TECH Company Information
Table 71. Ab&B BIO-TECH Description and Business Overview
Table 72. Ab&B BIO-TECH Influenza Subunit Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Ab&B BIO-TECH Influenza Subunit Vaccine Product
Table 74. Ab&B BIO-TECH Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Influenza Subunit Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Influenza Subunit Vaccine Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Seqirus, Inc Company Information
Table 81. Seqirus, Inc Description and Business Overview
Table 82. Seqirus, Inc Influenza Subunit Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Seqirus, Inc Influenza Subunit Vaccine Product
Table 84. Seqirus, Inc Recent Developments/Updates
Table 85. Zhongyianke Biology Company Information
Table 86. Zhongyianke Biology Description and Business Overview
Table 87. Zhongyianke Biology Influenza Subunit Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Zhongyianke Biology Influenza Subunit Vaccine Product
Table 89. Zhongyianke Biology Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Influenza Subunit Vaccine Distributors List
Table 93. Influenza Subunit Vaccine Customers List
Table 94. Influenza Subunit Vaccine Market Trends
Table 95. Influenza Subunit Vaccine Market Drivers
Table 96. Influenza Subunit Vaccine Market Challenges
Table 97. Influenza Subunit Vaccine Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Influenza Subunit Vaccine
Figure 2. Global Influenza Subunit Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Influenza Subunit Vaccine Market Share by Type: 2023 & 2030
Figure 4. Trivalent Vaccines Product Picture
Figure 5. Tetravalent Vaccine Product Picture
Figure 6. Global Influenza Subunit Vaccine Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Influenza Subunit Vaccine Market Share by Application: 2023 & 2030
Figure 8. Aldult
Figure 9. Child
Figure 10. Global Influenza Subunit Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Influenza Subunit Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Influenza Subunit Vaccine Sales (2019-2030) & (K Units)
Figure 13. Global Influenza Subunit Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 14. Influenza Subunit Vaccine Report Years Considered
Figure 15. Influenza Subunit Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Influenza Subunit Vaccine Revenue Share by Manufacturers in 2023
Figure 17. Global 5 and 10 Largest Influenza Subunit Vaccine Players: Market Share by Revenue in Influenza Subunit Vaccine in 2023
Figure 18. Influenza Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Influenza Subunit Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Influenza Subunit Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Influenza Subunit Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Influenza Subunit Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Influenza Subunit Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Influenza Subunit Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Influenza Subunit Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Influenza Subunit Vaccine Sales Market Share by Country (2019-2030)
Figure 41. Mexico Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Brazil Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Argentina Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Colombia Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Middle East and Africa Influenza Subunit Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Middle East and Africa Influenza Subunit Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Turkey Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. UAE Influenza Subunit Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Global Sales Market Share of Influenza Subunit Vaccine by Type (2019-2030)
Figure 51. Global Revenue Market Share of Influenza Subunit Vaccine by Type (2019-2030)
Figure 52. Global Influenza Subunit Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 53. Global Sales Market Share of Influenza Subunit Vaccine by Application (2019-2030)
Figure 54. Global Revenue Market Share of Influenza Subunit Vaccine by Application (2019-2030)
Figure 55. Global Influenza Subunit Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 56. Influenza Subunit Vaccine Value Chain
Figure 57. Influenza Subunit Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
